170 related articles for article (PubMed ID: 35984552)
1. Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
Jensen LR; Maier AD; Lomstein A; Graillon T; Hrachova M; Bota D; Ruiz-Patiño A; Arrieta O; Cardona AF; Rudà R; Furtner J; Roeckle U; Clement P; Preusser M; Scheie D; Broholm H; Kristensen BW; Skjøth-Rasmussen J; Ziebell M; Munch TN; Fugleholm K; Walter MA; Mathiesen T; Mirian C
Neurosurg Rev; 2022 Oct; 45(5):3067-3081. PubMed ID: 35984552
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis.
Mirian C; Duun-Henriksen AK; Maier A; Pedersen MM; Jensen LR; Bashir A; Graillon T; Hrachova M; Bota D; van Essen M; Spanjol P; Kreis C; Law I; Broholm H; Poulsgaard L; Fugleholm K; Ziebell M; Munch T; Walter MA; Mathiesen T
J Nucl Med; 2021 Apr; 62(4):507-513. PubMed ID: 32859705
[TBL] [Abstract][Full Text] [Related]
3. Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
Graillon T; Sanson M; Campello C; Idbaih A; Peyre M; Peyrière H; Basset N; Autran D; Roche C; Kalamarides M; Roche PH; Fuentes S; Tabouret E; Barrie M; Cohen A; Honoré S; Boucekine M; Baumstarck K; Figarella-Branger D; Barlier A; Dufour H; Chinot OL
Clin Cancer Res; 2020 Feb; 26(3):552-557. PubMed ID: 31969329
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Norden AD; Ligon KL; Hammond SN; Muzikansky A; Reardon DA; Kaley TJ; Batchelor TT; Plotkin SR; Raizer JJ; Wong ET; Drappatz J; Lesser GJ; Haidar S; Beroukhim R; Lee EQ; Doherty L; Lafrankie D; Gaffey SC; Gerard M; Smith KH; McCluskey C; Phuphanich S; Wen PY
Neurology; 2015 Jan; 84(3):280-6. PubMed ID: 25527270
[TBL] [Abstract][Full Text] [Related]
5. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
Chamberlain MC; Glantz MJ; Fadul CE
Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas.
Graillon T; Defilles C; Mohamed A; Lisbonis C; Germanetti AL; Chinot O; Figarella-Branger D; Roche PH; Adetchessi T; Fuentes S; Metellus P; Dufour H; Enjalbert A; Barlier A
J Neurooncol; 2015 Aug; 124(1):33-43. PubMed ID: 26015296
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin Receptor Theranostics for Refractory Meningiomas.
Salgues B; Graillon T; Horowitz T; Chinot O; Padovani L; Taïeb D; Guedj E
Curr Oncol; 2022 Aug; 29(8):5550-5565. PubMed ID: 36005176
[TBL] [Abstract][Full Text] [Related]
8. Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
Simó M; Argyriou AA; Macià M; Plans G; Majós C; Vidal N; Gil M; Bruna J
Cancer Chemother Pharmacol; 2014 May; 73(5):919-23. PubMed ID: 24619496
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unresectable skull base meningiomas with somatostatin analogs.
Schulz C; Mathieu R; Kunz U; Mauer UM
Neurosurg Focus; 2011 May; 30(5):E11. PubMed ID: 21529167
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Shih KC; Chowdhary S; Rosenblatt P; Weir AB; Shepard GC; Williams JT; Shastry M; Burris HA; Hainsworth JD
J Neurooncol; 2016 Sep; 129(2):281-8. PubMed ID: 27311730
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
Chamberlain MC
Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake.
Seystahl K; Stoecklein V; Schüller U; Rushing E; Nicolas G; Schäfer N; Ilhan H; Pangalu A; Weller M; Tonn JC; Sommerauer M; Albert NL
Neuro Oncol; 2016 Nov; 18(11):1538-1547. PubMed ID: 27106404
[TBL] [Abstract][Full Text] [Related]
13. Target therapies plus somatostatin analogs in NETs: a network meta-analysis.
Pusceddu S; Facciorusso A; Giacomelli L; Prinzi N; Corti F; Niger M; Milione M; Coppa J; Cascella T; Pulice I; Biamonte L; Papa S; Di Bartolomeo M; Shah A; Sacco R; de Braud F
Endocr Relat Cancer; 2021 Jun; 28(7):467-479. PubMed ID: 33979777
[TBL] [Abstract][Full Text] [Related]
14. Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.
Karajannis MA; Mauguen A; Maloku E; Xu Q; Dunbar EM; Plotkin SR; Yaffee A; Wang S; Roland JT; Sen C; Placantonakis DG; Golfinos JG; Allen JC; Vitanza NA; Chiriboga LA; Schneider RJ; Deng J; Neubert TA; Goldberg JD; Zagzag D; Giancotti FG; Blakeley JO
Mol Cancer Ther; 2021 Sep; 20(9):1584-1591. PubMed ID: 34224367
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy: What is its role in meningioma?
Sherman WJ; Raizer JJ
Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
[TBL] [Abstract][Full Text] [Related]
16. Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells.
Krug S; Mordhorst JP; Moser F; Theuerkorn K; Ruffert C; Egidi M; Rinke A; Gress TM; Michl P
PLoS One; 2019; 14(6):e0218953. PubMed ID: 31237925
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs.
Dasanu CA; Alvarez-Argote J; Limonadi FM; Codreanu I
Expert Opin Biol Ther; 2019 Feb; 19(2):99-104. PubMed ID: 30556741
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
[TBL] [Abstract][Full Text] [Related]
19. Unresectable Recurrent Multiple Meningioma: A Case Report with Radiological Response to Somatostatin Analogues.
Ortolá Buigues A; Crespo Hernández I; Jorquera Moya M; Díaz Pérez JÁ
Case Rep Oncol; 2016; 9(2):520-525. PubMed ID: 27721778
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of recurrent meningiomas.
Chamberlain MC; Barnholtz-Sloan JS
Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
